rs1060501700
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM2_SupportingPVS1PM3_Strong
This summary comes from the ClinGen Evidence Repository: The ATM c.8585-2A>C variant is predicted to result in a truncated protein that disrupts a critical functional domain (PVS1). This variant has been observed in a homozygous and compound heterozygous state (presumed) in multiple individuals with Ataxia-Telangiectasia (PM3_Strong; PMID:23322442, PMID:29665859). This variant is absent in the gnomAD v2.1.1 cohort (PM2_Supporting). In summary, this variant meets criteria to be classified as pathogenic based on the ACMG/AMP criteria applied as specified by the HBOP Variant Curation Expert Panel. LINK:https://erepo.genome.network/evrepo/ui/classification/CA16613454/MONDO:0016419/020
Frequency
Consequence
NM_000051.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATM | MANE Select | c.8585-2A>C | splice_acceptor intron | N/A | ENSP00000501606.1 | Q13315 | |||
| ATM | TSL:1 | c.8585-2A>C | splice_acceptor intron | N/A | ENSP00000388058.2 | Q13315 | |||
| C11orf65 | TSL:1 | c.*1196+7638T>G | intron | N/A | ENSP00000483537.1 | Q8NCR3-1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.91e-7 AC: 1AN: 1447690Hom.: 0 Cov.: 29 AF XY: 0.00000139 AC XY: 1AN XY: 721186 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at